Cargando…
Severe warm autoimmune hemolytic anemia in COVID-19 managed with least incompatible RBC product and glucocorticoids
Autores principales: | Hsieh, Tien-Chan, Sostin, Oleg |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7891115/ https://www.ncbi.nlm.nih.gov/pubmed/33604688 http://dx.doi.org/10.1007/s00277-021-04457-4 |
Ejemplares similares
-
COVID-19-ASSOCIATED DIRECT ANTIGLOBULIN TEST-NEGATIVE WARM AUTOIMMUNE HEMOLYTIC ANEMIA
por: HSIEH, TIEN-CHAN, et al.
Publicado: (2021) -
Immunotherapy Treatments of Warm Autoimmune Hemolytic Anemia
por: Liu, Bainan, et al.
Publicado: (2013) -
Educational Case: Warm Autoimmune Hemolytic Anemia
por: Arays, Ruta, et al.
Publicado: (2020) -
Ominous comorbidities: Small ventricular septal defect and warm autoimmune hemolytic anemia
por: Rad, Elaheh Malakan
Publicado: (2018) -
Warm Autoimmune Hemolytic Anemia: Clinical Profile and Management
por: Sudulagunta, Sreenivasa Rao, et al.
Publicado: (2017)